Hald 200 Soft Gelatin Capsule contains Progesterone (Natural Micronized) 200 mg, a key hormone involved in the regulation of the menstrual cycle and maintenance of pregnancy. This medication is primarily indicated for hormone replacement therapy in women with progesterone deficiency, management of amenorrhea, and support of luteal phase in assisted reproductive technology protocols. Progesterone plays a crucial role in preparing the endometrium for implantation and sustaining early pregnancy by modulating the uterine environment. Hald 200 is administered orally and is formulated as a soft gelatin capsule to enhance bioavailability and ensure consistent absorption. The natural micronized form of progesterone closely mimics endogenous hormone activity, minimizing adverse effects commonly associated with synthetic progestins. Dosage and duration of therapy should be individualized based on the patient’s clinical condition and response to treatment. Common side effects may include dizziness, headache, breast tenderness, and mild gastrointestinal disturbances. Contraindications include known hypersensitivity to progesterone, unexplained vaginal bleeding, and certain hormone-sensitive cancers. Caution is advised in patients with hepatic impairment or thromboembolic disorders. Regular monitoring by a healthcare professional is recommended to assess therapeutic efficacy and detect potential adverse reactions. Hald 200 Soft Gelatin Capsule should be used under strict medical supervision to ensure optimal outcomes.